Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Bronchodilators

  • Identification and characterisation of selective antagonists for TMEM16A(acd) isoform for the treatment of obstructive respiratory diseases
    P P saintot, C Carignani, J Phillips, C Virginio
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4414; DOI: 10.1183/13993003.congress-2022.4414
  • Effects of Salbutamol upon lung ventilation, hemodynamics and oxygen transport by arterial blood in chronic obstructive pulmonary disease (COPD)
    V Calancea, E Terna, C Martiniuc, S Eremciuc, I Sirbu, E Calancea, C Matcovschi, S Matcovschi
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3761; DOI: 10.1183/13993003.congress-2022.3761
  • The interest of magnesium sulfate nebulization in asthma exacerbation
    N MEBROUK, N El Hafidi, F Benbrahim, C Mahraoui
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3119; DOI: 10.1183/13993003.congress-2022.3119
  • Montelukast reverses β2-adrenoceptor tolerance in airway smooth muscle and shows a synergic effect in vivo
    I Cerqua, E Granato, M N Muscarà, G Cirino, B Severino, R Pavese, A Petti, G Caliendo, F Roviezzo
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3477; DOI: 10.1183/13993003.congress-2022.3477
  • EVELUT®: dyspnoea and symptom burden in COPD patients switching from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    R Buhl, M Dreher, M Mattiucci-Guehlke, S Eckhardt, C Taube, C Vogelmeier, R Buhl
    European Respiratory Journal Sep 2022, 60 (suppl 66) 3023; DOI: 10.1183/13993003.congress-2022.3023
  • A novel chronic guinea pig model of COPD using LPS and poly(I:C) exposure
    M De Looff, V Verschut, M E Woest, I C Gorter, K S Belfor, I S T Bos, M H De Jager, R Gosens, G Villetti, F Facchinetti, L E M Kistemaker
    European Respiratory Journal Sep 2022, 60 (suppl 66) 2396; DOI: 10.1183/13993003.congress-2022.2396
  • Relationship between severity of airflow obstruction and GOLD classification in COPD patients
    N Karamarković Lazarušić, B Butorac Petanjek, L Basara, M Jerić, G Pavliša
    European Respiratory Journal Sep 2022, 60 (suppl 66) 2232; DOI: 10.1183/13993003.congress-2022.2232
  • Ventilation and tissue oxygenation patterns induced by LABA and LAMA in COPD patients
    S Perez Bogerd, A Van Muylem, E Maufroy, Y El.Khloufi, S Zengin, V Faoro, A Malinovschi, A Michils
    European Respiratory Journal Sep 2022, 60 (suppl 66) 2083; DOI: 10.1183/13993003.congress-2022.2083
  • Effects of acute bronchodilators on ventilatory constraint and dyspnoea during exercise in patients with pulmonary arterial hypertension (PAH)
    E Schroeder, D C Berton, L R Diello, S D D Melati, M B Gazzana, E V M Ferreira, E V Ferreira
    European Respiratory Journal Sep 2022, 60 (suppl 66) 1898; DOI: 10.1183/13993003.congress-2022.1898
  • Overall response to anti-IL5/anti-IL5Rα treatment in severe asthma does not depend on initial bronchodilator responsiveness
    C Mümmler, H Suhling, N Kneidinger, R Buhl, M Kayser, N Drick, J Behr, T Welte, S Korn, K Milger
    European Respiratory Journal Sep 2022, 60 (suppl 66) 1894; DOI: 10.1183/13993003.congress-2022.1894

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 48
  • Acute lung injury and critical care (82)
  • Asthma and allergy (662)
  • CF and non-CF bronchiectasis (278)
  • COPD and smoking (909)
  • Epidemiology, occupational and environmental lung disease (214)
  • Genetics (60)
  • Interstitial and orphan lung disease (497)
  • Lung biology and experimental studies (318)
  • Lung cancer (281)
  • Lung imaging (45)
  • Lung structure and function (303)
  • Mechanisms of lung disease (145)
  • Paediatric pulmonology (394)
  • Pulmonary pharmacology and therapeutics (141)
  • Pulmonary vascular disease (523)
  • Respiratory clinical practice (171)
  • Respiratory infections and tuberculosis (970)
  • Sleep medicine (266)

Custom Text goes here

  • Most Read
  • Twitter
Loading

Tweets by @ERSpublications

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society